Tag archive for ‘Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA; TASE: TEVA)’
Gali Weinreb On Wednesday, December 17th, 2014

BioLineRX signs Novartis strategic cooperation deal

– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. –   Drug development company BiolineRX Ltd. (Nasdaq: BLRX); TASE:BLRX) More...

Shiri Habib-Valdhorn On Friday, July 18th, 2014

Glass Lewis backs Landa against Teva board

– Glass Lewis even recommends against board motions to which Benny Landa has not objected.   A day after ISS recommended investors to support Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA; More...

Jewish Business News On Thursday, March 27th, 2014

Dutch co reports generic Copaxone study success

– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug developer Synthon BV today announced success More...

Koby Yeshayahou On Wednesday, February 26th, 2014

Clal Biotech Selling Diabetes Treatment Co Andromeda

– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for an immediate More...

Wordpress site Developed by Fixing WordPress Problems